Biocon - M&A Summary and Business Overview

Healthcare ServicesCompany

Biocon M&A Summary

Biocon has acquired 2 companies, including 1 in the last 5 years.

Biocon’s largest acquisition to date was in 2022, when it acquired Viatris - Biosimilars for $3.3B. Biocon has acquired in 2 different US states. The Company’s most targeted sectors include life science (50%) and medical products (50%).

Biocon Business Overview

Where is Biocon headquartered?

Biocon is headquartered in Bengaluru, India.

What is Biocon’s revenue?

Biocon disclosed revenue of 141,958M INR for 2024 and 109,341M INR for 2023.

How many employees does Biocon have?

Biocon has 16,315 employees.

What sector is Biocon in?

Biocon is a healthcare services company.

When was Biocon founded?

Biocon was founded in 1978.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1
  • M&A Advisors 3

Biocon

Biocon Ltd.

20th KM, Hosur Road Electronics City,
Bengaluru, 560100
India,
+91 80 2808 2808
www.biocon.com

Biocon develops and sells biotechnology products for the pharmaceutical sector in India and internationally. Biocon was founded in 1978 and is based in Bengaluru, India.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 1 - - 1 - - 2
vol $3.3B $3.3B
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Viatris - Biosimilars 2022-02-28 3.3B USD Divestiture
Canonsburg, Pennsylvania
Nobex Corp. 2006-04-17 - Add-on Acquisition
Research Triangle Park, North Carolina
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (50%) 3.3B (100%) - -
Medical Products 1 (50%) - - -
Total 2 $3.3B - -

By Geo

State/Country Buy Value Sell Value
United States 2 3.3B - -
  Pennsylvania 1 3.3B - -
  North Carolina 1 - - -
Total 2 $3.3B - -

Top M&A Advisors

Financial Deals
Allegro Capital Advisors
1
Legal Deals
Goodwin Procter
1
Shardul Amarchand Mangaldas & Co.
1

Deal Values

buy # Total
> $1B 1 $3.3B
TOTAL $3.3B
Largest Viatris - Biosimilars
$3.3B (2022-02-28)

M&A Connections

Deals
Acquired from
Strategic(s)
50%
1 (50%)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.